Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Boston Scientific Corporation    BSX

BOSTON SCIENTIFIC CORPORATION

(BSX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
05/26/2020 05/27/2020 05/28/2020 05/29/2020 06/01/2020 Date
36.19(c) 37.14(c) 37.47(c) 37.99(c) 37.5(c) Last
12 272 250 9 472 886 8 924 318 10 062 952 6 174 670 Volume
+0.78% +2.63% +0.89% +1.39% -1.29% Change
More quotes
Financials (USD)
Sales 2020 9 695 M - -
Net income 2020 446 M - -
Net Debt 2020 7 980 M - -
P/E ratio 2020 130x
Yield 2020 -
Sales 2021 11 910 M - -
Net income 2021 1 602 M - -
Net Debt 2021 6 186 M - -
P/E ratio 2021 32,6x
Yield 2021 -
Capitalization 53 434 M 53 434 M -
EV / Sales 2020 6,33x
EV / Sales 2021 5,01x
Nbr of Employees 36 000
Free-Float 85,0%
More Financials
Company
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (61.1%): products used in cardiology surgeries (42.9% of net sales), cardiac rhythm management (29.6%), peripheral surgeries (21.2%), and other (6.4%); - endodontic surgery (30.8%): equipment used in endoscopy (57.3% of net... 
Sector
Advanced Medical Equipment & Technology
Calendar
06/02 | 08:00amPresentation
More about the company
Surperformance© ratings of Boston Scientific Corporat
Trading Rating : Investor Rating :
More Ratings
Latest news on BOSTON SCIENTIFIC CORPORAT
06/01BOSTON SCIENTIFIC : Launches DIRECTSENSE™ Technology
PR
05/29BOSTON SCIENTIFIC CORP : Entry into a Material Definitive Agreement, Financial S..
AQ
05/29BOSTON SCIENTIFIC : Certificate of Designations of Mandatory Convertible Preferr..
PU
05/28BOSTON SCIENTIFIC CORP : Entry into a Material Definitive Agreement, Material Mo..
AQ
05/27BOSTON SCIENTIFIC : Completes Approximately $2.0 Billion Aggregate Offerings of ..
PR
05/26BOSTON SCIENTIFIC : to Participate in Jefferies 2020 Healthcare Conference
PR
05/22BOSTON SCIENTIFIC : Raises $1.69 Billion in Upsized Offerings
DJ
05/22BOSTON SCIENTIFIC CORP : Other Events, Financial Statements and Exhibits (form 8..
AQ
05/21BOSTON SCIENTIFIC : Prices Offerings of Common Stock and Mandatory Convertible P..
PR
05/21BOSTON SCIENTIFIC : Shares Trading Lower on NYSE Thursday
DJ
05/20BOSTON SCIENTIFIC : Announces Public Offerings, Shares Move Lower After Hours
DJ
05/20BOSTON SCIENTIFIC : Announces Offerings of Common Stock and Mandatory Convertibl..
PR
05/18BOSTON SCIENTIFIC CORP : Entry into a Material Definitive Agreement, Other Event..
AQ
05/18BOSTON SCIENTIFIC : Completes $1.7 Billion Offering of Senior Notes
PR
05/15BOSTON SCIENTIFIC CORP : Other Events, Financial Statements and Exhibits (form 8..
AQ
More news
News in other languages on BOSTON SCIENTIFIC CORPORAT
06/01BOSTON SCIENTIFIC : Launches DIRECTSENSE™ Technology
05/29BOSTON SCIENTIFIC CORP : Entry into a Material Definitive Agreement, Financial S..
05/29BOSTON SCIENTIFIC : Certificate of Designations of Mandatory Convertible Preferr..
05/28BOSTON SCIENTIFIC CORP : Entry into a Material Definitive Agreement, Material Mo..
05/27BOSTON SCIENTIFIC : Completes Approximately $2.0 Billion Aggregate Offerings of ..
More news
Chart BOSTON SCIENTIFIC CORPORATION
Duration : Period :
Boston Scientific Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BOSTON SCIENTIFIC CORPORAT
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Average target price 42,85 $
Last Close Price 37,50 $
Spread / Highest target 33,3%
Spread / Average Target 14,3%
Spread / Lowest Target -22,7%
EPS Revisions
Managers
NameTitle
Michael F. Mahoney Chairman, President & Chief Executive Officer
Edward F. Mackey Executive Vice President-Operations
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Ian T. Meredith Global Chief Medical Officer & Executive VP
Jodi Eddy Chief Information Officer & SVP
Sector and Competitors
1st jan.Capitalization (M$)
BOSTON SCIENTIFIC CORPORATION-17.07%53 434
THERMO FISHER SCIENTIFIC7.53%137 968
DANAHER CORPORATION7.75%116 927
INTUITIVE SURGICAL, INC.-2.80%67 007
ILLUMINA, INC.10.15%53 715
SIEMENS HEALTHINEERS AG8.51%51 589